Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: Although many animal and human studies have been performed, the exact mechanisms of action whereby modafinil promotes wakefulness are still not completely understood. We aimed to investigate the functional effects of modafinil on motor cortex excitability in patients with narcolepsy by means of transcranial magnetic stimulation (TMS) techniques.

Methods: In a double-blind and placebo-controlled design, 24 drug-naive narcoleptic patients with cataplexy and 20 control subjects were administered modafinil or placebo over a period of 4 weeks. TMS was performed twice during the awake state before and at the end of treatment; measures of cortical excitability included central motor conduction time, resting motor threshold, short latency intracortical inhibition (SICI) and intracortical facilitation to paired-TMS. TMS measures were correlated with the conventional neurophysiological method of Multiple Sleep Latency Test (MSLT) and the subjective Epworth Sleepiness Scale (ESS).

Results: As previously reported, motor threshold and SICI were significantly increased in patients with narcolepsy; modafinil reversed this cortical hypoexcitability, but only SICI differences reached statistical significance. The Spearman rank correlation analysis revealed the highest correlation between SICI and the MSLT; a positive correlation was also found between SICI and the ESS, as well as between RMT and both measures of daytime sleepiness.

Conclusions: This represents the first report investigating effects of modafinil on cortical excitability in human narcolepsy. Since SICI is thought to be directly related to GABA(A) intracortical inhibitory activity, we demonstrated that the dose of modafinil that induces a satisfactory wakefulness-promoting response in narcoleptic patients also causes decrease in GABAergic transmission.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.sleep.2010.05.007DOI Listing

Publication Analysis

Top Keywords

narcoleptic patients
12
motor cortex
8
effects modafinil
8
patients narcolepsy
8
cortical excitability
8
motor threshold
8
correlation sici
8
modafinil
7
sici
6
motor
5

Similar Publications

Study Objectives: This study aimed to assess and quantify rapid eye movement (REM) sleep electromyographic (EMG) activity in narcolepsy patients.

Methods: The study involved 95 participants, including 25 with narcolepsy type 1 (NT1), 36 with narcolepsy type 2 (NT2), and 34 healthy controls (HC). We visually analyzed phasic, tonic, and "any" muscle activity for the submentalis (SM) and phasic for the anterior tibialis (AT) by both 3-s REM mini-epochs (3sRME) and 30-s REM epochs (30sRE) methods.

View Article and Find Full Text PDF

Narcolepsy type 1 is a neurological disorder typically emerging in childhood or adolescence, characterised by excessive daytime sleepiness, cataplexy and rapid eye movement sleep-related symptoms. Beyond its core features, increasing evidence suggests an impact on socio-cognitive development, including difficulties in understanding others' mental states. In this study, we aimed to clarify whether such impairments extend to more basic emotional processes.

View Article and Find Full Text PDF

Background: Narcolepsy is a chronic sleep disorder characterized mainly by excessive daytime sleepiness (EDS) and cataplexy in the case of narcolepsy type 1 (NT1). Pitolisant is a histamine 3 receptor antagonist/inverse agonist that reduces EDS and cataplexy in patients with narcolepsy.

Methods: We performed a prospective 5-year follow-up, non-interventional study of adults with NT1 and NT2 receiving pitolisant.

View Article and Find Full Text PDF

Background: Stimulants are potent treatments for central hypersomnolence disorders or attention-deficit/hyperactivity disorders/attention deficit disorders but concerns have been raised about their potential negative consequences and their increasing prescription rates.

Objective: We aimed to describe stimulant prescription trends in Switzerland from 2014 to 2021. Second, we aimed to analyze the characteristics of individuals who received stimulant prescriptions in 2021 and investigate the link between stimulant prescriptions and hospitalization rates in 2021, using hospitalization as a potential indicator of adverse health outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • Prader-Willi syndrome (PWS) is a rare genetic condition linked to cognitive and behavioral issues, obesity, and sleep problems, which may also involve autonomic nervous system dysfunction.
  • A study investigated heart rate variability and autonomic function during sleep and standing in children with PWS, comparing results with age-matched controls, revealing significant impairment in heart rate responses and high rates of sleep apnea among the PWS group.
  • Findings suggest decreased vagal modulation and possible sympathetic dysfunction in PWS children, which could increase their cardiovascular risks.
View Article and Find Full Text PDF